International journal of psychiatry in clinical practice · 2026
Depressive symptoms in patients with schizophrenia spectrum disorders and the impact on treatment motivation and satisfaction.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rothenberg Max, Lürzer Sabine, Winkler-Pjrek Edda, Mossaheb Nilufar, Friedrich Fabian, Winkler Dietmar
Аннотация
OBJECTIVES: Depressive symptoms are common in schizophrenia spectrum disorders and may influence how patients engage with treatment. This study examined whether depressive symptom severity affects motivation for treatment or satisfaction with inpatient care in patients with schizophrenia spectrum disorders.
METHODS: A total of 48 inpatients were divided into two groups: no or mild depressive symptoms (Group 1; N = 24) and moderate to severe depressive symptoms (Group 2; N = 24). Symptom severity was assessed at admission and discharge using the Hamilton depression rating scale and the positive and negative syndrome scale. Attitudes towards treatment (FPTM) were assessed at admission, and treatment satisfaction (ZUF-8) at discharge.
RESULTS: Treatment satisfaction was generally high and did not differ between depressive symptom groups. Greater depressive symptom severity was associated with higher mental distress. Higher initiative to engage in psychotherapy correlated positively with treatment satisfaction. Older age was also associated with greater satisfaction.
CONCLUSIONS: Treatment satisfaction in schizophrenia spectrum disorders appeared largely independent of depressive symptom severity. In contrast, patients' motivation to engage in treatment was closely related to satisfaction, suggesting that motivation may play a more decisive role in shaping treatment experience than symptom severity alone. Early support of treatment motivation and further integrative research are warranted.
METHODS: A total of 48 inpatients were divided into two groups: no or mild depressive symptoms (Group 1; N = 24) and moderate to severe depressive symptoms (Group 2; N = 24). Symptom severity was assessed at admission and discharge using the Hamilton depression rating scale and the positive and negative syndrome scale. Attitudes towards treatment (FPTM) were assessed at admission, and treatment satisfaction (ZUF-8) at discharge.
RESULTS: Treatment satisfaction was generally high and did not differ between depressive symptom groups. Greater depressive symptom severity was associated with higher mental distress. Higher initiative to engage in psychotherapy correlated positively with treatment satisfaction. Older age was also associated with greater satisfaction.
CONCLUSIONS: Treatment satisfaction in schizophrenia spectrum disorders appeared largely independent of depressive symptom severity. In contrast, patients' motivation to engage in treatment was closely related to satisfaction, suggesting that motivation may play a more decisive role in shaping treatment experience than symptom severity alone. Early support of treatment motivation and further integrative research are warranted.